Ivertac 6 Tablet contains Ivermectin 6 mg, an antiparasitic agent widely used for the treatment of various parasitic infections. Ivermectin acts by binding selectively to glutamate-gated chloride ion channels in the nerve and muscle cells of invertebrates, leading to increased permeability to chloride ions, hyperpolarization, and subsequent paralysis and death of the parasite. It is effective against a broad spectrum of parasites including strongyloidiasis, onchocerciasis, and other nematode infections. Ivertac 6 is indicated for the treatment of intestinal strongyloidiasis, onchocerciasis, and other susceptible parasitic infestations. The tablet should be administered orally, with dosage and duration determined based on the specific infection and patient weight. It is generally well tolerated, but adverse effects may include dizziness, nausea, diarrhea, and mild skin reactions. Use with caution in patients with impaired liver function or those with a history of hypersensitivity to ivermectin. Ivertac 6 is contraindicated in children weighing less than 15 kg and in pregnant or breastfeeding women unless the potential benefits outweigh the risks. Proper diagnosis and adherence to prescribed dosage are essential to ensure efficacy and minimize resistance development. Always consult a healthcare professional before initiating therapy.